Hims & Hers shares have gyrated this year after the company started offering copycat versions of GLP-1 injections that are not approved by the FDA.

Trump’s picks, made late Friday, did little to dispel the notion that the nation’s federal health agencies are facing a major ...

Unauthorized switching of Affordable Care Act plans appears to have tapered off in recent weeks based on an almost one-third ...

Mount Sinai Health System has opened a $100 million building dedicated to artificial intelligence.

A measure to speed pre-approvals and expand reporting is backed by a majority of Congress, but that may not be enough to get ...

High-acuity patients often lead to increased expenses for providers, given the specialized clinicians and equipment needed to ...